After winning approval in the United States back in September, Sanofi Genzyme’s multiple sclerosis drug, aubagio, has won approval for use in Australia. The Australian Therapeutic Goods ...

PE-backed specialty pharma company Kelso Pharma appointed Giovanni Mauri as general manager of its recently acquired Italian ...

A growing momentum for earlier treatment of psoriasis has the potential to improve outcomes with oral therapies and biologics used to treat psoriasis, said Strober. The momentum can be traced to an ...

At Genzyme, Dr. Kaye also held various roles ... Medical Officer leading the drive to develop Exondys 51 a pioneering drug for Duchenne muscular dystrophy. He went on to serve as CEO of Sarepta ...

The study results confirm the drug’s safety, Dellavalle said ... Regeneron, Roche, Sanofi-Genzyme, Sun Pharma, Takeda, Tarsus, UCB, Union, and Vyntex. Dellavalle reported no relevant financial ...

Multiple sclerosis (MS) is a chronic immune-mediated demyelinating disease of the central nervous system characterised by inflammatory lesions and neurodegeneration. Diagnosis often occurs in women of ...

Viridian Therapeutics, Inc. , a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced the appointment of Jeff ...

The FDA and the European Medicines Agency both granted Elelyso ... which resulted from a viral contamination incident at Genzyme’s Allston Landing facility in Massachusetts. Unfettered access to ...

Correspondence to Professor Maria A Rocca, Neuroimaging Research Unit, Division of Neuroscience, IRCCS Ospedale San Raffaele, Milano 20132, Italy; rocca.mara{at}hsr.it PRLs are considered relatively ...

WASHINGTON − The Supreme Court on Wednesday unanimously overturned a lower court’s decision that the Food and Drug Administration incorrectly blocked companies from selling fruit- and candy ...